NCT02979730

Impact of Rapid Flu Testing in BMC ED

Proposal to Evaluate the Impact of Point of Care Liat Influenza A/B Testing in the Emergency Department at Boston Medical Center

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 233 (actual)
• Sponsor: Boston Medical Center · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to compare Emergency Department patients who undergo influenza testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who agree to participate will have their samples randomly assigned to be tested on either at the core lab, or on the POC device. The current turnaround time for samples sent to the laboratory is approximately two hours; investigators expect that the point of care device can reduce this time. Investigators will determine if the time to disposition and the administration of antibiotics is different in the group undergoing POC influenza testing compared to those undergoing laboratory-based influenza testing

Conditions

• Influenza-Like Illness
• Influenza

Interventions

Type	Name	Description
OTHER	Core Lab Test	For patients randomized to the Core Lab Testing Arm, ED physicians will order an influenza test to be performed in the core lab.
OTHER	ED Point of Care Test	For patients randomized to the ED Point of Care Testing Arm, the Research Assistant will perform influenza testing in the Emergency Department, using the Cobas Liat Influenza A/B assay

Timeline

• Start date: 2017-02-07
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2016-12-02
• Last updated: 2018-07-24

Locations

1 site across 1 country: United States